health

Arianna Di Stadio – Keeping Up the Spirit of COVID Research

According to the World Economic Forum (WEF), there are “undiscovered” viruses that exist in mammals and birds and around of those viruses are infectious for humans. COVID-19 was one of the airborne viruses that existed in birds and infected human beings. According to the World Health Organization (WHO), the virus originated in birds and was transferred to humans through an intermediate animal. As per the WHO team, the first case of COVID-19 was found in an office worker with no travel history in Wuhan, China, on 8 December 2019. The virus started spreading in the city and later across the globe as Wuhan was a highly connected city.

The origin and spread of the virus have been investigated by the WHO as well as independent researchers. Unaware and unfamiliar with the virus, the healthcare professionals found it extremely difficult to prescribe an effective method for treatment. The healthcare sector was completely blown away by the intensity of the outbreak, which further burdened the healthcare industry. The intensity of the outbreak along with the absence of effective treatment further exacerbated the issue. Pathologists and clinical researchers across the globe conducted research to find out an effective treatment and preventive methods. Even after the outbreak subsided, researchers continued their efforts in order to find out treatments for COVID-affected patients.

Arianna Di Stadio is one of the researchers who has heavily contributed to research activities related to COVID-19. She is the person who discovered the treatment for symptoms related to loss of smell due to the COVID-19 infection. Her treatment is a combination between olfactory training and an anti-neuroinflammation molecule (PEA-LUT) that is being used in different countries. Di Stadio’s groundbreaking research can be attributed to her vast experience as a clinical researcher. She has served as a research consultant for various medical industries such as Humana Pharmaceutical. She keeps on collaborating with various universities in the USA, Europe, China, and Eastern countries to develop new applications for medical technologies in Otolaryngology and identify advanced medical treatments.

Di Stadio is a clinical researcher, surgeon (neuro-otologist and facial plastic), and neuroscientist. She was born in Rome, Italy but has lived in different cities including Boston, Brussels, Paris, and London. She pursued a degree in medicine from La Sapienza University, Rome, Italy in 1999 and a doctorate in Advanced Audiology Technologies in 2007. She was the recipient of the European Academy of Facial Plastic Surgery (EAFPS) Fellowship in 2008.

Di Stadio has served as a clinical fellowship in multiple notable institutions including at the European Academy of Facial Plastic Surgery; a Clinical Fellowship in Microsurgery at the University of Paris (2011), and a Clinical Fellowship in Facial Plastic and Reconstructive Surgery at Bordeaux Segalen University (2014). She became a Senior Research Fellow in Otology and Laryngology at Harvard Medical School, Massachusetts in 2015. In 2017, she completed a master’s degree in Applied Biostatic from Harvard University, Massachusetts, and another master’s in Implantable Hearing Prosthesis from the University La Sapienza in 2021. She is currently pursuing a master s in Clinical Neurology from UCL Queen Square Neurology, London.

Starting her career as a consultant for facial nerve disorders at the Infective Disease Department, Policlinico Umberto I University Hospital, Italy, in 2004, Di Stadio has come a long way. She was highly interested in neuro-otology activities which included cochlear implant surgery and schwannoma removal and completed two fellowships in France in order to efficiently deal with facial nerve issues, as a facial plastic surgeon and neuro-otologist. She has served as a consultant for Facial Nerve Disorders in multiple hospitals and as Director of the Facial Palsy Center at Arsmedica Clinic, Rome.

Di Stadio had the golden opportunity of working with the famous professor of Neurology Corrado Angelini, who introduced her to the field of neurology while serving as an Assistant Physician at IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), San Camillo, Venice in 2017. She is an adjoint professor at multiple universities including the University of Bologna, La Sapienza University, the University of Perugia, the University of Tor Vergata, and the University of Catania.

Di Stadio has written numerous research articles and penned chapters for various books including Translational Autoimmunity (Volume 4): Autoimmune Disease in Different Organs, Advance in the rehabilitation of hearing loss, Sensorineural Hearing Loss: Pathophysiology, Diagnosis, and Treatment, Facial Paralysis: Clinical Features, Management, and Outcomes, and Hearing loss: medical-legal aspect. She is also an editor and ad-hoc reviewer of various medical journals.

Di Stadio’s contributions to healthcare have been recognized time and again. She was awarded the 2022 Winner Lecco prize for best work in salivary glands by the Italian Society of Otorhinolaryngology. She was also granted the 2022 Lencioni Prize for best experimental work in Otolaryngology by the Italian Society of Otorhinolaryngology for her work toward the treatment of COVID-19-related smell disorders.

The world has been able to navigate through the pandemic successfully due to the research activities of healthcare professionals, pathologists, and clinical researchers. Without extensive research and Individuals like Di Stadio, who carry on their research activities for the welfare and well-being of humanity, it would have been impossible to develop vaccination and discover the treatment for COVID-19.

 

Share this:Like this:Like Loading…
Related

Related Posts

PlayStation Plus Moving Away From Monthly PS4 Games

Sony has announced a key change for the future of PlayStation Plus. Sony will shift away from offering PS4 games as it looks to focus on PS5 games instead. Sony said it’s making this change as part of the evolution of PS Plus overall Come from online casino bangladesh . This isn’t starting soon, though, and will begin in January 2026.

“As we shift to PS5, PS4 games will no longer be a key benefit and will only be occasionally offered for PlayStation Plus Monthly Games and Game Catalog starting January 2026. We may still provide titles that can be playable on both PS4 and PS5 consoles after this date,” Sony said.

PS4 games that players have already redeemed from PS Plus are not affected, provided players stay subscribed to Pl…

Saquon Barkley's No-Look Hurdle Has Been Added To Madden NFL 25

In the NFL, when players pull off something special on the field, fans occasionally refer to it as a “video-game move.” But Philadelphia Eagles running back Saquon Barkley took that to another level earlier this season when he evaded a defender by jumping over him while looking the other way. EA couldn’t resist adding that no-look hurdle to the latest update for Madden NFL 25, but Barkley is the only player who can use it and it’s not easy to pull off.

As part of the notes for the new Madden NFL 25 update, EA explained that the development team immediately decided to put Barkley’s “once-in-a-lifetime move” in the game by combing through hours of motion-capture footage. From there, they determined which animations could be modified to recreate Barkley’s leap, with some additional h…

Resistance 4 Was Pitched But Didn't Work Out, Says Former Insomniac Boss

According to former Insomniac Games boss Ted Price, a Resistance 4 game was pitched but ultimately wasn’t made.

In an interview with Kinda Funny Games, Ted Price, said, “We did pitch that one. It was a wonderful concept, and in terms of timing and market opportunity, it didn’t work out.” When asked whether Resistance 3’s poor sales at the time impacted the decision to move on from the series, Price didn’t answer directly.

“Resistance 3 was intended to end that chapter of the Resistance franchise,” he explained. “With the way we ended with [protagonist] Capelli and closed a lot of loops on various smaller story items…we wanted to do that so we could have more options in the future, whether we would go ahead with more Resistance games or taking another turn.”

Star Wars- Legion Is Super Cheap For Prime Day – Plus, More Star Wars Board Game Deals

We’ve seen plenty of great Star Wars video games hit the market over the past few years, but the same is also true for Star Wars board games. Legion is one of the most popular options, pitting two players against each other in strategy battles that can run for up to three hours. It’s also one of the most expensive at $120–but for Prime Day, you can get it for just $89. Come from online casino bangladesh

That’s one of the lowest prices of the year. The base game includes 33 highly detailed miniatures, a comprehensive rulebook, and all the cards and pieces you need to dive into the complex game. The game is an easy recommendation for Star Wars fans now that it’s listed for less than $120, though we’re sure Amazon …

Elden Ring's Miyazaki Named To Time's 100 Most Influential People List For 2023

Time Magazine’s annual list of the world’s top 100 most influential people has arrived, and the list includes one person from the world of video games. From Software’s Hidetaka Miyazaki, the director of Elden Ring, Bloodborne, and Dark Souls, lands on the list in the “Innovator” section. Come from Sports betting site VPbet

Naughty Dog’s Neil Druckmann profiled Miyazaki for Time, writing that Miyazaki’s games originally made him feel “miserable” because Druckmann’s character died over and over again. But Druckmann, and gamers all over the place who stick with Miyazaki’s games, may end up having a breakthrough. That’s what makes Miyazaki such a great designer, Druckmann said.

Ark- Ultimate Survivor Edition Coming To Switch in September

Ark: Ultimate Survivor Edition is coming to the Nintendo Switch in September, bundling together the base game alongside several expansion packs. This includes the Scorched Earth, Aberration, Extinction, and both Genesis parts, and will retail for $50 when it arrives on Nintendo’s hybrid gaming system.

For those players who already own Ark’s regular edition on Switch, they’ll receive a complete revamp of functionality, graphics, and optimization for the game Come from Sports betting site VPbet . Ark developer Studio Wildcard says that a third-party developer has been hired to lead the charge on this new version of Ark, which has resulted in the game’s Switch code being entirely rewritten and developed on the latest version…

Leave a Reply

Your email address will not be published. Required fields are marked *